Market Cap 2.22B
Revenue (ttm) 802.80M
Net Income (ttm) 53.51M
EPS (ttm) N/A
PE Ratio 33.55
Forward PE 69.08
Profit Margin 6.67%
Debt to Equity Ratio 0.00
Volume 994,300
Avg Vol 991,624
Day's Range N/A - N/A
Shares Out 29.57M
Stochastic %K 5%
Beta 1.16
Analysts Sell
Price Target $119.07

Company Profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerv...

Industry: Medical Devices
Sector: Healthcare
Phone: (844) 672-4357
Address:
5500 Wayzata Blvd., Suite 1600, Golden Valley, United States
mp1514
mp1514 Oct. 30 at 9:23 PM
$INSP CEO for this company is a shitbag!!!
0 · Reply
kadixon
kadixon Oct. 24 at 3:06 PM
$INSP I hate this stonk. The biggest diçk tease of all time
1 · Reply
CH_Expat
CH_Expat Oct. 24 at 3:04 PM
$INSP Okay, might be back sooner than expected.
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 10:27 AM
Jefferies updates rating for Inspire Medical Systems ( $INSP ) to Hold, target set at 160 → 85.
0 · Reply
CH_Expat
CH_Expat Oct. 21 at 2:43 PM
$INSP Sold for 2k gain, family food for two months. This and LNTH are undervalued while having some sort if issues, so trading them feels safe at these levels.
0 · Reply
Tartufo
Tartufo Oct. 20 at 6:16 PM
0 · Reply
CH_Expat
CH_Expat Oct. 17 at 4:09 PM
$INSP He is short in INSP even at this bombed out levels, so opening a position here looks like a good idea.
1 · Reply
CasInvestments
CasInvestments Oct. 15 at 6:13 PM
$INSP this stock has been down 11 of the last 12 months despite increasing revenue, being profitable and announcing a $200M buyback of shares. Not to mention expanding rapidly and the Inspire V device an absolute success. Waiting to buy is just greed at this point. Missing out a buy for a 5-10% discount when this may very well be over $100 by Q3 earnings is pure greed. Making this post so I can come back to when this is over $300 by end of 2027.
2 · Reply
anachartanalyst
anachartanalyst Oct. 15 at 6:02 PM
$INSP https://anachart.com/wp-content/uploads/ana_temp/1760551352_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 3:17 PM
Truist Securities has adjusted their stance on Inspire Medical Systems ( $INSP ), setting the rating to Hold with a target price of 125 → 90.
0 · Reply
Latest News on INSP
Inspire Medical: Hiccups For The Sleep Business

Aug 23, 2025, 8:56 AM EDT - 2 months ago

Inspire Medical: Hiccups For The Sleep Business


Inspire Medical Stock Strays Off Course Amid Structural Setback

Aug 7, 2025, 12:41 PM EDT - 3 months ago

Inspire Medical Stock Strays Off Course Amid Structural Setback


mp1514
mp1514 Oct. 30 at 9:23 PM
$INSP CEO for this company is a shitbag!!!
0 · Reply
kadixon
kadixon Oct. 24 at 3:06 PM
$INSP I hate this stonk. The biggest diçk tease of all time
1 · Reply
CH_Expat
CH_Expat Oct. 24 at 3:04 PM
$INSP Okay, might be back sooner than expected.
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 10:27 AM
Jefferies updates rating for Inspire Medical Systems ( $INSP ) to Hold, target set at 160 → 85.
0 · Reply
CH_Expat
CH_Expat Oct. 21 at 2:43 PM
$INSP Sold for 2k gain, family food for two months. This and LNTH are undervalued while having some sort if issues, so trading them feels safe at these levels.
0 · Reply
Tartufo
Tartufo Oct. 20 at 6:16 PM
0 · Reply
CH_Expat
CH_Expat Oct. 17 at 4:09 PM
$INSP He is short in INSP even at this bombed out levels, so opening a position here looks like a good idea.
1 · Reply
CasInvestments
CasInvestments Oct. 15 at 6:13 PM
$INSP this stock has been down 11 of the last 12 months despite increasing revenue, being profitable and announcing a $200M buyback of shares. Not to mention expanding rapidly and the Inspire V device an absolute success. Waiting to buy is just greed at this point. Missing out a buy for a 5-10% discount when this may very well be over $100 by Q3 earnings is pure greed. Making this post so I can come back to when this is over $300 by end of 2027.
2 · Reply
anachartanalyst
anachartanalyst Oct. 15 at 6:02 PM
$INSP https://anachart.com/wp-content/uploads/ana_temp/1760551352_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Oct. 15 at 3:17 PM
Truist Securities has adjusted their stance on Inspire Medical Systems ( $INSP ), setting the rating to Hold with a target price of 125 → 90.
0 · Reply
OffHisGame88
OffHisGame88 Oct. 14 at 2:52 PM
$INSP all the bad news is pretty priced in. No reason this can't grow more than 16% in 2026.
0 · Reply
ZacksResearch
ZacksResearch Oct. 13 at 5:44 PM
$INSP's tech shines, but shares slide! Is the market missing the big picture? 🤔 Despite a promising clinical showcase for the Inspire V system, shares dropped 6.2% and are down 59.5% YTD. With improved safety and 20% faster surgeries, it's set for stronger adoption and revenue growth 📈. Discover why it might be a hidden gem 👉 https://www.zacks.com/stock/news/2767705/insp-shares-down-despite-strong-clinical-data-from-inspire-v-trials?cid=sm-stocktwits-2-2767705-body-15787&ADID=SYND_STOCKTWITS_TWEET_2_2767705_BODY_15787
0 · Reply
ZacksResearch
ZacksResearch Oct. 13 at 4:44 PM
$INSP drops even after strong trial results — what’s going on? ⚠️ New data from Inspire V shows strong safety, quicker procedures, and higher patient adherence, yet shares still slipped. Market reaction looks out of sync with the fundamentals. Full breakdown here 👉 https://www.zacks.com/stock/news/2767705/insp-shares-down-despite-strong-clinical-data-from-inspire-v-trials?cid=sm-stocktwits-2-2767705-teaser-15774&ADID=SYND_STOCKTWITS_TWEET_2_2767705_TEASER_15774
0 · Reply
CH_Expat
CH_Expat Oct. 12 at 1:48 PM
If you are interested in fully bombed out Medtech, here are some tickers: $INSP $RXST $LUNG.
1 · Reply
CH_Expat
CH_Expat Oct. 10 at 6:07 PM
$INSP 330 at 75.94 USD. Thanks for the opportunity.
0 · Reply
JarvisFlow
JarvisFlow Oct. 7 at 5:35 PM
Evercore ISI Group has adjusted their stance on Inspire Medical Systems ( $INSP ), setting the rating to Outperform with a target price of 150 → 125.
1 · Reply
mortermer
mortermer Oct. 6 at 10:47 PM
$INSP these dumb things are horrible For MRI. Just stupid. I have wires running to my hypoglossal nerve. lol.
0 · Reply
slippageKing
slippageKing Oct. 5 at 7:55 AM
$INSP Healthcare technology innovation. Breaking to new highs. Institutional accumulation pattern evident. Momentum strong.
0 · Reply
SweepCastApp
SweepCastApp Oct. 4 at 6:56 AM
$INSP: Unusual Options Activity Alerted PUT flow observed 62x contracts at Strike price of $65 Exp on 12/19/2025 with Premium of $30K and showing BEARISH Sentiment
0 · Reply
CH_Expat
CH_Expat Oct. 3 at 5:45 PM
$IDYA 30% up here, not going anywhere. Quick info for my followers: I might be more shifting to Medtech value plays near term as bios ran heavily. Initiated LUNG at 1.61 USD and might do a starter at bombed out $INSP soon. Bios on watch for a correction: $CRNX, $SNDX and APGE.
2 · Reply
shap9
shap9 Oct. 3 at 12:44 PM
$INSP time to rebound
0 · Reply
Golferdo
Golferdo Oct. 1 at 1:54 PM
$INSP wonder how low they can take this.
1 · Reply